NCT00508469

Adherence Assessment With Travalert Dosing Aid

Adherence of Patients Using Travalert® for Instillation of a Fixed Combination of Travoprost 0.004%/Timolol 0.5% Compared to a Concomitant Regimen of Travoprost 0.004% and Timolol 0.5%

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 102 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to compare adherence in patients on a fixed combination of travoprost 0.004%/timolol 0.5% and patients on a concomitant combination of travoprost 0.004% and timolol 0.5% using the Travalert® device.

Conditions

• Open-angle Glaucoma
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	Travoprost 0.004%/timolol 0.5% fixed combination eye drops (DuoTrav)	One drop in the study eye once daily at 9 p.m. for six months using the Travalert device.
DRUG	Travoprost 0.004% eye drops	One drop in the study eye once daily at 9 p.m. for six months using the Travalert device.
DRUG	Timolol 0.05% eye drops	One drop in the study eye twice daily at 9 a.m. and 9 p.m. for six months using the Travalert device.
DEVICE	Travalert Dosing Aid	Approved device used with study medication to record time of instillation and quantify dosing

Timeline

• Start date: 2007-10-01
• Primary completion: 2010-01-01
• Completion: 2010-01-01
• First posted: 2007-07-30
• Last updated: 2012-07-12
• Results posted: 2012-07-12

Locations

1 site across 1 country: Spain